2-(3-(Benzyloxy)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

6,7-Dihydro-2-methylpyrazolo[1,5-a]pyrazin-4(5H)-one, 98%, 250mg

(R)-4-(4-CHLOROPHENYL)OXAZOLIDIN-2-ONE, 95.0%, 1g

(3R,4R)-1-CBZ-4-FLUORO-3-PIPERIDINAMINE, REL, 95.0%, 1g

DL-�-(4-Hydroxy-3-methoxy-phenyl)alanine, 97.0%, 1g

1-(Cyclopropylsulfonyl)-1,4-diazepane, 95%, 1g

3-Chlorophenyl hydrazine hydrochloride, 99.0%, 1kg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldec-9-enoic acid, 95.0%, 5g

Fmoc-PEG2-C2-NHS ester, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)non-8-enoic acid, 95.0%, 10g

5-BROMO-2-(DIMETHOXYMETHYL)PYRIDINE, 95%, 250mg

1,1,2,2-Tetrafluoroethyl 2,2,3,3-Tetrafluoropropyl Ether>95.0%(GC)25g

tert-Butyl benzyl(5-chloro-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate, 97%, 5g